Cargando…
Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
An intelligent insulin delivery system is highly desirable for diabetes management. Herein, we developed a novel glucose-responsive multivesicular liposome (MVL) for self-regulated insulin delivery using the double emulsion method. Glucose-responsive MVLs could effectively regulate insulin release i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781467/ https://www.ncbi.nlm.nih.gov/pubmed/35056918 http://dx.doi.org/10.3390/pharmaceutics14010021 |
_version_ | 1784638093346734080 |
---|---|
author | Liu, Guangqu He, Suping Ding, Yu Chen, Cai Cai, Qingchun Zhou, Wei |
author_facet | Liu, Guangqu He, Suping Ding, Yu Chen, Cai Cai, Qingchun Zhou, Wei |
author_sort | Liu, Guangqu |
collection | PubMed |
description | An intelligent insulin delivery system is highly desirable for diabetes management. Herein, we developed a novel glucose-responsive multivesicular liposome (MVL) for self-regulated insulin delivery using the double emulsion method. Glucose-responsive MVLs could effectively regulate insulin release in response to fluctuating glucose concentrations in vitro. Notably, in situ released glucose oxidase catalyzed glucose enrichment on the MVL surface, based on the combination of (3-fluoro-4-((octyloxy)carbonyl)phenyl)boronic acid and glucose. The outer MVL membrane was destroyed when triggered by the local acidic and H(2)O(2)-enriched microenvironment induced by glucose oxidase catalysis in situ, followed by the further release of entrapped insulin. Moreover, the Alizarin red probe and molecular docking were used to clarify the glucose-responsive mechanism of MVLs. Utilizing chemically induced type 1 diabetic rats, we demonstrated that the glucose-responsive MVLs could effectively regulate blood glucose levels within a normal range. Our findings suggest that glucose-responsive MVLs with good biocompatibility may have promising applications in diabetes treatment. |
format | Online Article Text |
id | pubmed-8781467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87814672022-01-22 Multivesicular Liposomes for Glucose-Responsive Insulin Delivery Liu, Guangqu He, Suping Ding, Yu Chen, Cai Cai, Qingchun Zhou, Wei Pharmaceutics Article An intelligent insulin delivery system is highly desirable for diabetes management. Herein, we developed a novel glucose-responsive multivesicular liposome (MVL) for self-regulated insulin delivery using the double emulsion method. Glucose-responsive MVLs could effectively regulate insulin release in response to fluctuating glucose concentrations in vitro. Notably, in situ released glucose oxidase catalyzed glucose enrichment on the MVL surface, based on the combination of (3-fluoro-4-((octyloxy)carbonyl)phenyl)boronic acid and glucose. The outer MVL membrane was destroyed when triggered by the local acidic and H(2)O(2)-enriched microenvironment induced by glucose oxidase catalysis in situ, followed by the further release of entrapped insulin. Moreover, the Alizarin red probe and molecular docking were used to clarify the glucose-responsive mechanism of MVLs. Utilizing chemically induced type 1 diabetic rats, we demonstrated that the glucose-responsive MVLs could effectively regulate blood glucose levels within a normal range. Our findings suggest that glucose-responsive MVLs with good biocompatibility may have promising applications in diabetes treatment. MDPI 2021-12-22 /pmc/articles/PMC8781467/ /pubmed/35056918 http://dx.doi.org/10.3390/pharmaceutics14010021 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Guangqu He, Suping Ding, Yu Chen, Cai Cai, Qingchun Zhou, Wei Multivesicular Liposomes for Glucose-Responsive Insulin Delivery |
title | Multivesicular Liposomes for Glucose-Responsive Insulin Delivery |
title_full | Multivesicular Liposomes for Glucose-Responsive Insulin Delivery |
title_fullStr | Multivesicular Liposomes for Glucose-Responsive Insulin Delivery |
title_full_unstemmed | Multivesicular Liposomes for Glucose-Responsive Insulin Delivery |
title_short | Multivesicular Liposomes for Glucose-Responsive Insulin Delivery |
title_sort | multivesicular liposomes for glucose-responsive insulin delivery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781467/ https://www.ncbi.nlm.nih.gov/pubmed/35056918 http://dx.doi.org/10.3390/pharmaceutics14010021 |
work_keys_str_mv | AT liuguangqu multivesicularliposomesforglucoseresponsiveinsulindelivery AT hesuping multivesicularliposomesforglucoseresponsiveinsulindelivery AT dingyu multivesicularliposomesforglucoseresponsiveinsulindelivery AT chencai multivesicularliposomesforglucoseresponsiveinsulindelivery AT caiqingchun multivesicularliposomesforglucoseresponsiveinsulindelivery AT zhouwei multivesicularliposomesforglucoseresponsiveinsulindelivery |